Both Combined or Sequential Use with Immune Checkpoint Inhibitors on Cetuximab-Treated Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Improve the Overall Survival
Oral Oncology（2021）
Key words
Cetuximab,Immune checkpoint inhibitor,Head and neck cancer,Platinum-resistance,Recurrence,Metastasis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined